For example, the combination of RARbeta with either DAPK or RASSF1A showed a significantly shorter overall survival of those malignant mesothelioma patients who had both genes methylated compared to those with only one or no epigenetic alteration [52]. This evidence concerns the gene DAPK1 and malignant mesothelioma.